Yeah but holding the rights and being able to exercise them in practice are two distinct concepts.
Ask him whether Acadia can block development of 2591 in an undisclosed indication in North America if they decide to - the answer is yes. Its not matter for debate, unless there are provisions in the agreement that we are not privy to and that have not been published, that negate the explicit restrictive powers that Acadia have.
If he says no, they can't block Neuren in advancing undisclosed indications in North America, then ask him how? Which provision in the contract negates their right to block our development?
Ask for it in writing and I will calm the farm!
For what its worth, I hope you are both right and they used good lawyers that have a solid plan for how they exercise their rights in practice - cause the contract gives Acadia scope to frustrate our efforts, unless someone else has another credible interpretation of the contract they are willing to share.
NEU Price at posting:
$19.03 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)